Pharmaceutical manufacturers of Liquid formulation

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~$1.9 billion in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices. Piramal Foundation has initiatives in primary healthcare, nutrition, water, and social sector ecosystems.

We are an international CDMO specialized in soft gel capsules, non-sterile liquid formulations, and R&D offerings. Our expertise lies in contract manufacturing of pharmaceuticals, medical devices, dietary supplements, veterinary products, and beauty products. Our primary focus is on producing soft capsules and non-sterile liquid forms.

Cambrex stands as a prominent global contract development and manufacturing organization (CDMO) delivering comprehensive analytical and IND enabling services, along with drug substance development and manufacturing throughout the entire drug lifecycle. Boasting 40 years of expertise and a workforce of 2,000 professionals catering to international clients from North America and Europe, Cambrex is a reliable ally in both the branded and generic markets for API development and manufacturing. The company provides a variety of specialized drug substance technologies and capabilities.

DPT, a subsidiary of Mylan, is a prominent contract development and manufacturing organization, known for its expertise in semi-solid and liquid forms of medication. Established in 1938, DPT offers top-notch development and manufacturing solutions to our clients. With a workforce of around 1,000 individuals in San Antonio, Texas, DPT possesses unparalleled experience, resources, and capability to effectively cater to the needs of its clients.

Bioplus is a comprehensive partner providing pharmaceutical solutions from start to finish for contract services. They are an integrated Biopharmaceutical, Health, Wellness and Nutrition company, with a strong focus on research and development to create innovative products and formulations globally. Their expertise lies in Finished Dosage Forms & Speciality API’s with emphasis on using green technology production methods. They are ready for Phase 3 manufacturing of New Chemical Entities (NCE) for myopia. Bioplus Life Sciences is a prominent company offering contract research, development, distribution and manufacturing services for licensed and over-the-counter (OTC) pharmaceuticals. Serving a wide range of clients from small businesses to well-known brands across more than 60 countries, Bioplus has numerous manufacturing sites and a workforce of over 2,000 employees. With over 70 years in the industry, Bioplus adheres to strict regulations and provides cutting-edge solutions with advanced technology. They have complete in-house capabilities for product development, manufacturing and distribution of various delivery formats, all compliant with international regulations.

Bora Pharmaceuticals is a leading global cGMP CDMO that specializes in the production of basic to intricate Solid dose, Semi-Solid, and Liquid pharmaceutical Rx and OTC products for late-phase clinical through commercial manufacturing and packaging

We are a pharmaceutical CDMO established in 2020 through the merger of C.O.C. Farmaceutici and Tubilux Pharma, two thriving Italian enterprises with extensive expertise in this field. We are the foremost company in Italy specializing in the contract development, production, and filling of pharmaceuticals and medical devices for ophthalmic, nasal, respiratory, and topical uses. Our clientele consists of multinational corporations, large conglomerates, as well as small to medium-sized pharmaceutical firms, whether with or without manufacturing facilities. Our products are experiencing increasing demand across Europe, the Middle East, North Africa, and the United States.

Oncomed Manufacturing a.s. operates as a Contract Development and Manufacturing Organization specializing in the manufacturing of potent and anticancer (cytotoxic) injectables at clinical and commercial scale. The company's focus includes small molecule APIs with an end-to-end solution, as well as more innovative large molecule drugs such as ADCs, HPAPI proteins, mAb, and oligonucleotides.

Chemineau produces fluid and semi-solid wellness products packaged in tubes, containers, mists, and bag-on-valve systems. Our adaptable and small-scale teams blend proficiency and passion to tackle your industrial and developmental obstacles in pharmaceuticals, OTC, and personal care specialties, regardless of the level of intricacy and advancement. Supported by industrial expertise and cutting-edge machinery, Chemineau possesses the capability to provide a range of adaptable services and production solutions, encompassing pioneering and intricate galenics, highly potent formulas, especially micro & nano dosed emulsions.

One Pharma, a rapidly growing producer of pharmaceutical finished dosages, was founded in Athens in 1991 under the name Pharmanel. It manufactures more than 200 formulations covering various therapeutic areas and serves over 50 clients in 15 different nations. One Pharma undergoes regular audits by the National Organization for Medicines to ensure compliance with European standards, in addition to other regulatory bodies. Its facility adheres to EU-GMP and ISO 9001:2015 criteria. One Pharma gives its clients an advantage in introducing generic products, along with supplementary services that assist them in maintaining competitiveness and profitability throughout the products' lifecycle.